1. Home
  2. RCUS vs GRPN Comparison

RCUS vs GRPN Comparison

Compare RCUS & GRPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCUS
  • GRPN
  • Stock Information
  • Founded
  • RCUS 2015
  • GRPN 2008
  • Country
  • RCUS United States
  • GRPN United States
  • Employees
  • RCUS N/A
  • GRPN N/A
  • Industry
  • RCUS Biotechnology: Pharmaceutical Preparations
  • GRPN Advertising
  • Sector
  • RCUS Health Care
  • GRPN Consumer Discretionary
  • Exchange
  • RCUS Nasdaq
  • GRPN Nasdaq
  • Market Cap
  • RCUS 906.4M
  • GRPN 791.8M
  • IPO Year
  • RCUS 2018
  • GRPN 2011
  • Fundamental
  • Price
  • RCUS $8.36
  • GRPN $34.21
  • Analyst Decision
  • RCUS Buy
  • GRPN Buy
  • Analyst Count
  • RCUS 10
  • GRPN 4
  • Target Price
  • RCUS $23.75
  • GRPN $29.00
  • AVG Volume (30 Days)
  • RCUS 1.2M
  • GRPN 1.6M
  • Earning Date
  • RCUS 08-07-2025
  • GRPN 07-29-2025
  • Dividend Yield
  • RCUS N/A
  • GRPN N/A
  • EPS Growth
  • RCUS N/A
  • GRPN N/A
  • EPS
  • RCUS N/A
  • GRPN N/A
  • Revenue
  • RCUS $141,000,000.00
  • GRPN $486,660,000.00
  • Revenue This Year
  • RCUS N/A
  • GRPN $3.48
  • Revenue Next Year
  • RCUS $28.73
  • GRPN $8.16
  • P/E Ratio
  • RCUS N/A
  • GRPN N/A
  • Revenue Growth
  • RCUS N/A
  • GRPN N/A
  • 52 Week Low
  • RCUS $6.50
  • GRPN $7.75
  • 52 Week High
  • RCUS $18.98
  • GRPN $41.26
  • Technical
  • Relative Strength Index (RSI)
  • RCUS 39.01
  • GRPN 57.12
  • Support Level
  • RCUS $7.91
  • GRPN $32.85
  • Resistance Level
  • RCUS $8.87
  • GRPN $41.26
  • Average True Range (ATR)
  • RCUS 0.48
  • GRPN 2.00
  • MACD
  • RCUS -0.14
  • GRPN -0.60
  • Stochastic Oscillator
  • RCUS 8.24
  • GRPN 21.14

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About GRPN Groupon Inc.

Groupon Inc acts as the middleman between consumers and merchants, offering products and services at discounts via its online store. It offers consumers daily deals from local merchants. The company's operations are organized into two segments: North America and International. The company generates the majority of its revenue from North America. The company generates revenue from transactions during which the company generates commissions by selling goods or services on behalf of third-party merchants. Revenue also includes commissions the company earn when customers make purchases with retailers using digital coupons accessed through its digital properties.

Share on Social Networks: